Wet Age-Related Macular Degeneration Responds Equally To Avastin And Lucentis
The one year results from a study into whether two drug treatments (Lucentis and Avastin), are equally effective in treating neovascular or wet age-related macular degeneration (wet AMD), have been reported at an international research meeting in Fort Lauderdale, Florida.* The findings will also appear online in the leading journal Ophthalmology...